Beyond the increasing complexity of the immunomodulatory HLA-G molecule

The biology of human natural killer-cell subsets

Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975 · see citing works

A Class I Antigen, HLA-G, Expressed in Human Trophoblasts

Kovats, S., Main, E. K., Librach, C. L., Stubblebine, M., Fisher, S. J., & DeMars, R. (1990) · Science · doi:10.1126/science.2326636 · Cited by 1,406 · see citing works

A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells

Colonna, M., Navarro, F., Bellón, T., Llano, M., Garcı́a, P., Samaridis, J., Ångman, L., Cella, M., & López‐Botet, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1809 · Cited by 948 · see citing works

A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer Cells

Rajagopalan, S., & Long, E. O. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1093 · Cited by 721 · see citing works

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis

Rouas‐Freiss, N., Bras‐Gonçalves, R., Menier, C., Dausset, J. B., & Carosella, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11520 · Cited by 699 · see citing works

Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G

Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V. M., Allan, D., Makadzange, T., Rowland‐Jones, S., Willcox, B. E., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1431057100 · Cited by 559 · see citing works

Tregs and rethinking cancer immunotherapy

Curiel, T. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31202 · Cited by 558 · see citing works

What is trogocytosis and what is its purpose?

Joly, E., & Hudrisier, D. (2003) · Nature Immunology · doi:10.1038/ni0903-815 · Cited by 543 · see citing works

Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens.

Ishitani, A., & Geraghty, D. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3947 · Cited by 516 · see citing works

A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment.

Geraghty, D. E., Koller, B. H., & Orr, H. T. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9145 · Cited by 514 · see citing works

HLA-E Surface Expression Depends on Binding of TAP-Dependent Peptides Derived from Certain HLA Class I Signal Sequences

Lee, N., Goodlett, D. R., Ishitani, A., Marquardt, H., & Geraghty, D. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4951 · Cited by 505 · see citing works

Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules.

Colonna, M., Samaridis, J., Cella, M., Ångman, L., Allen, R. L., O’Callaghan, C. A., Dunbar, P. R., Ogg, G. S., Cerundolo, V., & Rolink, A. G. (1998) · PubMed · Cited by 499 · see citing works

Cutting Edge: Soluble HLA-G1 Triggers CD95/CD95 Ligand-Mediated Apoptosis in Activated CD8+ Cells by Interacting with CD8

Fournel, S., Aguerre‐Girr, M., Huc, X., Lenfant, F., Alam, A., Toubert, A., Bensussan, A., & Bouteiller, P. P. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6100 · Cited by 462 · see citing works

Cutting Edge: Human Myelomonocytic Cells Express an Inhibitory Receptor for Classical and Nonclassical MHC Class I Molecules

Colonna, M., Samaridis, J., Cella, M., Ångman, L., Allen, R. L., O’Callaghan, C. A., Dunbar, R., Ogg, G. S., Cerundolo, V., & Rolink, A. G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3096 · Cited by 457 · see citing works

HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance

Paul, P., Rouas‐Freiss, N., Khalil, I., Moreau, P., Riteau, B., Gal, F. A. L., Avril, M.-F., Dausset, J. B., Guillet, J. G., & Carosella, E. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4510 · Cited by 432 · see citing works

Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule.

Ellis, S. A., Palmer, M. S., & McMichael, A. J. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.2.731 · Cited by 393 · see citing works

HLA-G Molecules: from Maternal–Fetal Tolerance to Tissue Acceptance

Carosella, E. D., Moreau, P., LeMaoult, J., Discorde, M. L., Dausset, J. B., & Rouas‐Freiss, N. (2003) · Advances in immunology · doi:10.1016/s0065-2776(03)81006-4 · Cited by 370 · see citing works

Soluble HLA‐A,‐B,‐C and ‐G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation

Contini, P., Ghio, M., Poggi, A. D., Filaci, G., Indiveri, F., Ferrone, S., & Puppo, F. (2002) · European Journal of Immunology · doi:10.1002/immu.200390015 · Cited by 359 · see citing works

Activation of NK Cells by an Endocytosed Receptor for Soluble HLA-G

Rajagopalan, S., Bryceson, Y. T., Kuppusamy, S. P., Geraghty, D. E., van der Meer, A., Joosten, I., & Long, E. O. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0040009 · Cited by 356 · see citing works

The α 1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors?

Rouas‐Freiss, N., Bras‐Gonçalves, R., Kirszenbaum, M., Dausset, J. B., & Carosella, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5249 · Cited by 352 · see citing works

HLA-G in human reproduction: aspects of genetics, function and pregnancy complications

Hviid, T. V. F. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi048 · Cited by 333 · see citing works

A Functional Role of HLA-G Expression in Human Gliomas: An Alternative Strategy of Immune Escape

Wiendl, H., Mitsdoerffer, M., Hofmeister, V., Wischhusen, J., Bornemann, A., Meyermann, R., Weiss, E. H., Melms, A., & Weller, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4772 · Cited by 325 · see citing works

HLA-G2, -G3, and -G4 Isoforms Expressed as Nonmature Cell Surface Glycoproteins Inhibit NK and Antigen-Specific CTL Cytolysis

Riteau, B., Rouas‐Freiss, N., Menier, C., Paul, P., Dausset, J. B., & Carosella, E. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5018 · Cited by 324 · see citing works

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes

Gal, F. L., Riteau, B., Sedlik, C., Khalil, I., Menier, C., Dausset, J. B., Guillet, J., Carosella, E. D., & Rouas‐Freiss, N. (1999) · International Immunology · doi:10.1093/intimm/11.8.1351 · Cited by 316 · see citing works

Tolerization of dendritic cells by HLA‐G

Ristich, V., Liang, S., Zhang, W., Wu, J., & Horuzsko, A. (2005) · European Journal of Immunology · doi:10.1002/eji.200425741 · Cited by 315 · see citing works

HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4 + T cells

LeMaoult, J., Krawice-Radanne, I., Dausset, J. B., & Carosella, E. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401922101 · Cited by 314 · see citing works

HLA‐G up‐regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells

LeMaoult, J., Zafaranloo, K., Danff, C. L., & Carosella, E. D. (2005) · The FASEB Journal · doi:10.1096/fj.04-1617fje · Cited by 303 · see citing works

Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line.

Ellis, S. A., Sargent, I. L., Redman, C., & McMichael, A. J. (1986) · PubMed Central · Cited by 289 · see citing works

Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response

Davis, D. M. (2007) · Nature reviews. Immunology · doi:10.1038/nri2020 · Cited by 288 · see citing works

Expression of HLA-G in human cornea, an immune-privileged tissue

Discorde, M. L., Moreau, P., Sabatier, P., Legeais, J., & Carosella, E. D. (2003) · Human Immunology · doi:10.1016/j.humimm.2003.08.346 · Cited by 270 · see citing works

Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells

LeMaoult, J., Caumartin, J., Daouya, M., Favier, B., Rond, S. L., González, Á., & Carosella, E. D. (2006) · Blood · doi:10.1182/blood-2006-05-024547 · Cited by 266 · see citing works

Cutting Edge: Induction of IFN-γ Production but Not Cytotoxicity by the Killer Cell Ig-Like Receptor KIR2DL4 (CD158d) in Resting NK Cells

Rajagopalan, S., Fu, J., & Long, E. O. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1877 · Cited by 259 · see citing works

HLA-G Proteins in Cancer: Do They Provide Tumor Cells with an Escape Mechanism?

Rouas‐Freiss, N., Moreau, P., Ferrone, S., & Carosella, E. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0097 · Cited by 247 · see citing works

HLA-G suppresses proliferation of CD4+ T-lymphocytes

Bainbridge, D. R. J., Ellis, S. A., & Sargent, I. L. (2000) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(00)00070-x · Cited by 244 · see citing works

Human Leukocyte Antigen-G Expression After Heart Transplantation Is Associated With a Reduced Incidence of Rejection

Lila, N., Amrein, C., Guillemain, R., Chevalier, P. G., Latrémouille, C., Fabiani, J., Dausset, J. B., Carosella, E. D., & Carpentier, A. (2002) · Circulation · doi:10.1161/01.cir.0000015075.89984.46 · Cited by 244 · see citing works

Trogocytosis‐based generation of suppressive NK cells

Caumartin, J., Favier, B., Daouya, M., Guillard, C., Moreau, P., Carosella, E. D., & LeMaoult, J. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601570 · Cited by 243 · see citing works

Efficient Leukocyte Ig-like Receptor Signaling and Crystal Structure of Disulfide-linked HLA-G Dimer

Shiroishi, M., Kuroki, K., Ose, T., Rasubala, L., Shiratori, I., Arase, H., Tsumoto, K., Kumagai, I., Kohda, D., & Maenaka, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512305200 · Cited by 226 · see citing works

Implication of HLA-G molecule in heart-graft acceptance

Lila, N., Carpentier, A., Amrein, C., Khalil, I., Dausset, J. B., & Carosella, E. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02386-2 · Cited by 224 · see citing works

2-(8-Hydroxy-6-Methoxy-1-Oxo-1H-2-Benzopyran-3-yl) Propionic Acid, an Inhibitor of Angiogenesis, Ameliorates Renal Alterations in Obese Type 2 Diabetic Mice

Ichinose, K., Maeshima, Y., Yamamoto, Y., Kinomura, M., Hirokoshi, K., Kitayama, H., Takazawa, Y., Sugiyama, H., Yamasaki, Y., Agata, N., et al. (2006) · Diabetes · doi:10.2337/diabetes · Cited by 217 · see citing works

Disulfide bond-mediated dimerization of HLA-G on the cell surface

Boyson, J. E., Erskine, R. A., Whitman, M. C., Chiu, M. T.-K., Lau, J. M., Koopman, L. A., Valter, M. M., Angelisová, P., Hořejšı́, V., & Strominger, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212643199 · Cited by 210 · see citing works

A homodimeric complex of HLA‐G on normal trophoblast cells modulates antigen‐presenting cells via LILRB1

Apps, R., Gardner, L., Sharkey, A., Holmes, N., & Moffett, A. (2007) · European Journal of Immunology · doi:10.1002/eji.200737089 · Cited by 204 · see citing works

Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells

Fons, P., Chabot, S., Cartwright, J. E., Lenfant, F., L'Faqihi‐Olive, F., Giustiniani, J., Herault, J.-P., Guéguen, G., Bono, F., Savi, P., et al. (2006) · Blood · doi:10.1182/blood-2005-12-019919 · Cited by 200 · see citing works

HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation

Feger, U., Tolosa, E., Huang, Y., Waschbisch, A., Biedermann, T., Melms, A., & Wiendl, H. (2007) · Blood · doi:10.1182/blood-2006-11-057125 · Cited by 197 · see citing works

HLA-G is a potential tumor marker in malignant ascites.

Singer, G., Rebmann, V., Chen, Y., Liu, H. T., Ali, S. Z., REINSBERG, J., McMaster, M., Pfeiffer, K. A., Chan, D. W., Wardelmann, E., et al. (2003) · PubMed · Cited by 194 · see citing works

HLA-G: a shield against inflammatory aggression

Carosella, E. D., Moreau, P., Aractingi, S., & Rouas‐Freiss, N. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02007-5 · Cited by 186 · see citing works

KIR2DL4 Is an IL-2-Regulated NK Cell Receptor That Exhibits Limited Expression in Humans but Triggers Strong IFN-γ Production

Kikuchi-Maki, A., Yusa, S.-I., Catina, T. L., & Campbell, K. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3415 · Cited by 183 · see citing works

Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule

Lozano, J. M., González, R., Kindelán, J. M., Rouas‐Freiss, N., Caballos, R., Dausset, J. B., Carosella, E. D., & Peña, J. (2002) · AIDS · doi:10.1097/00002030-200202150-00005 · Cited by 182 · see citing works

Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity

Wiendl, H., Feger, U., Mittelbronn, M. G. A., Jack, C. S., Schreiner, B., Stadelmann, C., Antel, J. P., Brück, W., Meyermann, R., Bar‐Or, A., et al. (2005) · Brain · doi:10.1093/brain/awh609 · Cited by 180 · see citing works

HLA-G inhibits the allogeneic proliferative response

Riteau, B., Menier, C., Khalil, I., Sedlik, C., Dausset, J. B., Rouas‐Freiss, N., & Carosella, E. D. (1999) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(99)00034-0 · Cited by 177 · see citing works

Evidence to Support the Role of HLA-G5 in Allograft Acceptance through Induction of Immunosuppressive/ Regulatory T Cells

Rond, S. L., Azéma, C., Krawice-Radanne, I., Dürrbach, A., Guettier, C., Carosella, E. D., & Rouas‐Freiss, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3266 · Cited by 173 · see citing works

Soluble HLA-G circulates in maternal blood during pregnancy

Hunt, J. S., Jadhav, L., Chu, W., Geraghty, D. E., & Ober, C. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106762 · Cited by 173 · see citing works

The Class I HLA Repertoire of Pancreatic Islets Comprises the Nonclassical Class Ib Antigen HLA-G

Cirulli, V., Zalatan, J., McMaster, M., Prinsen, R. C., Salomon, D. R., Ricordi, C., Torbett, B. E., Meda, P., & Crisá, L. (2006) · Diabetes · doi:10.2337/db05-0731 · Cited by 170 · see citing works

HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia

Nückel, H., Rebmann, V., Dürig, J., Dührsen, U., & Grosse‐Wilde, H. (2004) · Blood · doi:10.1182/blood-2004-08-3335 · Cited by 165 · see citing works

Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis

Menier, C., Rabreau, M., Challier, J.-C., Discorde, M. L., Carosella, E. D., & Rouas‐Freiss, N. (2004) · Blood · doi:10.1182/blood-2004-03-0809 · Cited by 162 · see citing works

Crystal structure of HLA-G: A nonclassical MHC class I molecule expressed at the fetal–maternal interface

Clements, C. S., Kjer‐Nielsen, L., Kostenko, L., Hoare, H. L., Dunstone, M. A., Moses, E. K., Freed, K. A., Brööks, A. G., Rossjohn, J., & McCluskey, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409676102 · Cited by 160 · see citing works

Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer

Ye, S.-R., Yang, H., Li, K., Dong, D., Lin, X., & Yie, S.-M. (2007) · Modern Pathology · doi:10.1038/modpathol.3800751 · Cited by 159 · see citing works

Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation

Créput, C., Dürrbach, A., Menier, C., Guettier, C., Samuel, D., Dausset, J. B., Charpentier, B., Carosella, E. D., & Rouas‐Freiss, N. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00354-4 · Cited by 155 · see citing works

HLA-G and NK Receptor Are Expressed in Psoriatic Skin

Aractingi, S., Briand, N., Danff, C. L., Viguier, M. A., Bachelez, H., Michel, L., Dubertret, L., & Carosella, E. D. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61675-6 · Cited by 154 · see citing works

Soluble HLA-G Inhibits Cell Cycle Progression in Human Alloreactive T Lymphocytes

Bahri, R., Hirsch, F., Josse, A., Rouas‐Freiss, N., Bidère, N., Vasquez, A. C., Carosella, E. D., Charpentier, B., & Dürrbach, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1331 · Cited by 143 · see citing works

Complexes of HLA-G Protein on the Cell Surface Are Important for Leukocyte Ig-Like Receptor-1 Function

Gonen‐Gross, T., Achdout, H., Gazit, R., Hanna, J. H., Mizrahi, S., Markel, G., Goldman‐Wohl, D., Yagel, S., Hořejšı́, V., Levy, O., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1343 · Cited by 142 · see citing works

Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture

Kanai, T. (2001) · Molecular Human Reproduction · doi:10.1093/molehr/7.2.195 · Cited by 142 · see citing works

Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.

Bukur, J., Rebmann, V., Grosse‐Wilde, H., Luboldt, H., Ruebben, H., Drexler, I., Sutter, G., Huber, C., & Seliger, B. (2003) · PubMed · Cited by 137 · see citing works

CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance

Naji, A., Rond, S. L., Dürrbach, A., Krawice-Radanne, I., Créput, C., Daouya, M., Caumartin, J., LeMaoult, J., Carosella, E. D., & Rouas‐Freiss, N. (2007) · Blood · doi:10.1182/blood-2007-04-083139 · Cited by 136 · see citing works

SHP-1- and Phosphotyrosine-Independent Inhibitory Signaling by a Killer Cell Ig-Like Receptor Cytoplasmic Domain in Human NK Cells

Yusa, S.-I., Catina, T. L., & Campbell, K. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5047 · Cited by 132 · see citing works

HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83+ dendritic cells expresses HLA-G as a membrane-bound and soluble protein

Mallet, V., Blaschitz, A., Crisá, L., Schmitt, C., Fournel, S., King, A., Loke, Y. W., Dohr, G., & Bouteiller, P. P. L. (1999) · International Immunology · doi:10.1093/intimm/11.6.889 · Cited by 129 · see citing works

Modulation of HLA-G Expression in Human Neural Cells after Neurotropic Viral Infections

Lafon, M., Prehaud, C. J. N., Mégret, F., Lafage, M., Mouillot, G., Roa, M., Moreau, P., Rouas‐Freiss, N., & Carosella, E. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15226-15237.2005 · Cited by 126 · see citing works

KIR2DL4 (CD158d) Genotype Influences Expression and Function in NK Cells

Goodridge, J. P., Witt, C. S., Christiansen, F., & Warren, H. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1768 · Cited by 126 · see citing works

Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA‐G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients

Rond, S. L., LeMaoult, J., Créput, C., Menier, C., Deschamps, M., Friec, G. L., Amiot, L., Dürrbach, A., Dausset, J. B., Carosella, E. D., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200324266 · Cited by 121 · see citing works

Membrane-bound HLA-G activates proliferation and interferon- production by uterine natural killer cells

van der Meer, A. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah032 · Cited by 117 · see citing works

Placental Cell Expression of HLA-G2 Isoforms Is Limited to the Invasive Trophoblast Phenotype

Morales, P. J., Pace, J. L., Platt, J. S., Phillips, T. A., Morgan, K., Fazleabas, A. T., & Hunt, J. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6215 · Cited by 116 · see citing works

Soluble HLA-G Expression and Renal Graft Acceptance

Qiu, J., Terasaki, P. I., Miller, J. S., Mizutani, K., Cai, J., & Carosella, E. D. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01417.x · Cited by 116 · see citing works

The CD85J/Leukocyte Inhibitory Receptor-1 Distinguishes between Conformed and β2-Microglobulin-Free HLA-G Molecules

Gonen‐Gross, T., Achdout, H., Arnon, T. I., Gazit, R., Stern‐Ginossar, N., Hořejšı́, V., Goldman‐Wohl, D., Yagel, S., & Mandelboim, O. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.4866 · Cited by 114 · see citing works

Human Neuroblastoma Cells Trigger an Immunosuppressive Program in Monocytes by Stimulating Soluble HLA-G Release

Morandi, F., Levreri, I., Bocca, P., Galleni, B., Raffaghello, L., Ferrone, S., Prigione, I., & Pistoia, V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4588 · Cited by 113 · see citing works

HLA-G revisited

Carosella, E. D., Dausset, J. B., & Kirszenbaum, M. (1996) · Immunology Today · doi:10.1016/0167-5699(96)30055-8 · Cited by 109 · see citing works

NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains

Selvakumar, A., Steffens, U., & Dupont, B. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02647.x · Cited by 103 · see citing works

Regulatory T cells and tumour immunity – observations in mice and men

Gallimore, A., & Godkin, A. J. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02748.x · Cited by 100 · see citing works

NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G

Maki, G., Hayes, G. M., Naji, A., Tyler, T., Carosella, E. D., Rouas‐Freiss, N., & Gregory, S. A. (2008) · Leukemia · doi:10.1038/leu.2008.15 · Cited by 98 · see citing works

Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA‐G expression correlates with malignant transformation, high inflammatory infiltration and HLA‐A1 genotype

Ibrahim, E. C., Aractingi, S., Allory, Y., Borrini, F., Dupuy, A., Duvillard, P., Carosella, E. D., Avril, M.-F., & Paul, P. (2003) · International Journal of Cancer · doi:10.1002/ijc.11456 · Cited by 94 · see citing works

CXCR5-deficient mice develop functional germinal centers in the splenic T cell zone

Voigt, I. M.-V., Camacho, S. A., de Boer, B. A., Lipp, M., Förster, R., & Berek, C. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200002)30:2 · Cited by 94 · see citing works

Soluble HLA‐G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells

Gros, F., Cabillic, F., Toutirais, O., Maux, A. L., Sebti, Y., & Amiot, L. (2008) · European Journal of Immunology · doi:10.1002/eji.200736918 · Cited by 89 · see citing works

Soluble HLA-G Molecules Are Increased during Acute Leukemia, Especially in Subtypes Affecting Monocytic and Lymphoid Lineages'

Gros, F., Sebti, Y., de Guiber, S., Branger, B., Bernard, M., Fauchet, R., & Amiot, L. (2006) · Neoplasia · doi:10.1593/neo.05703 · Cited by 84 · see citing works

HLA-G Expression in Atopic Dermatitis

Khosrotehrani, K., Danff, C. L., Reynaud-Mendel, B., Dubertret, L., Carosella, E. D., & Aractingi, S. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01487.x · Cited by 76 · see citing works

Synthesis of β2‐microglobulin‐free, disulphide‐linked HLA‐G5 homodimers in human placental villous cytotrophoblast cells

Morales, P. J., Pace, J. L., Platt, J. S., Langat, D. K., & Hunt, J. S. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02623.x · Cited by 75 · see citing works

Homozygous HLA‐G*0105N healthy individuals indicate that membrane‐anchored HLA‐G1 molecule is not necessary for survival

Castro, M. J., Morales, P., Rojo‐Amigo, R., Martı́nez-Laso, J., Allende, L. M., Varela, P., García-Berciano, M., Guillén‐perales, J., & Arnaiz‐Villena, A. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.560305.x · Cited by 71 · see citing works

Expression of functional soluble human leucocyte antigen‐G molecules in lymphoproliferative disorders

Sebti, Y., Maux, A. L., Gros, F., de Guibert, S., Pangault, C., Rouas‐Freiss, N., Bernard, M., & Amiot, L. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06647.x · Cited by 68 · see citing works

Heat shock proteins 70 and 60 share common receptors which are expressed on human monocyte-derived but not epidermal dendritic cells

Lipsker, D. M., Ziylan, U., Spehner, D., Proamer, F., Bausinger, H., Jeannin, P., Salamero, J., Bohbot, A., Cazenave, J., Drillien, R., et al. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200202)32:2 · Cited by 62 · see citing works

HLA-G Expression is a Fundamental Prerequisite to Pregnancy

Rizzo, R., Melchiorri, L., Stignani, M., & Baricordi, O. R. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.10.012 · Cited by 61 · see citing works

Switch ofHLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis

Rouas‐Freiss, N., Bruel, S., Menier, C., Marcou, C., Moreau, P., & Carosella, E. D. (2005) · International Journal of Cancer · doi:10.1002/ijc.21151 · Cited by 60 · see citing works

HLA-G*0105N Null Allele Encodes Functional HLA-G Isoforms1

Discorde, M. L., Danff, C. L., Moreau, P., Rouas‐Freiss, N., & Carosella, E. D. (2005) · Biology of Reproduction · doi:10.1095/biolreprod.104.037986 · Cited by 55 · see citing works

Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients

Poláková, K. X. N., Kŕcová, M., Kuba, D. M., & Russ, G. (2003) · Leukemia Research · doi:10.1016/s0145-2126(02)00228-x · Cited by 40 · see citing works

Soluble Human Leukocyte Antigen-G: A New Strategy for Monitoring Acute and Chronic Rejections After Heart Transplantation

Lila, N., Amrein, C., Guillemain, R., Chevalier, P. G., Fabiani, J., & Carpentier, A. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.01.001 · Cited by 36 · see citing works

Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukaemia

Mizuno, S., Emi, N., Kasai, M., Ishitani, A., & Saito, H. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02345.x · Cited by 35 · see citing works

sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation

Luque, J., Torres, M. I., Aumente, M. D., Lozano, J. M., García-Jurado, G., González, R., Álvarez-López, M. R., Arizón, J. M., & Peña, J. (2006) · Transplant Immunology · doi:10.1016/j.trim.2006.09.009 · Cited by 29 · see citing works

A novel sandwich ELISA for α1 domain based detection of soluble HLA-G heavy chains

Juch, H., Blaschitz, A., Daxböck, C., Rueckert, C., Kofler, K., & Dohr, G. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.09.016 · Cited by 23 · see citing works

Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation

Bernardo, M. E., & Fibbe, W. E. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.09.006 · Cited by 1,389 · see citing works

The Role of the Immune System in Autism Spectrum Disorder

Meltzer, A., & Van de Water, J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.158 · Cited by 533 · see citing works

Immunoregulation by Mesenchymal Stem Cells: Biological Aspects and Clinical Applications

Castro-Manrreza, M. E., & Montesinos, J. J. (2015) · Journal of Immunology Research · doi:10.1155/2015/394917 · Cited by 400 · see citing works

The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer

Bremnes, R. M., Al-Shibli, K. I., Dønnem, T., Sirera, R., Al‐Saad, S., Andersen, S., Stenvold, H., Camps, C., & Busund, L. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182037b76 · Cited by 370 · see citing works

Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association

Donadi, E. A., Castelli, E. C., Arnaiz‐Villena, A., Roger, M., Rey, D., & Moreau, P. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0580-7 · Cited by 371 · see citing works

Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy

Riera-Domingo, C., Audigé, A., Granja, S., Cheng, W.-C., Ho, P.-C., Baltazar, F., Stockmann, C., & Mazzone, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2019 · Cited by 310 · see citing works

A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G

Carosella, E. D., Ploussard, G., LeMaoult, J., & Desgrandchamps, F. (2015) · European Urology · doi:10.1016/j.eururo.2015.02.032 · Cited by 225 · see citing works

The genetic structure of 3′untranslated region of the HLA-G gene: polymorphisms and haplotypes

Castelli, E. C., Mendes‐Junior, C. T., Deghaide, N. H. S., de Albuquerque, R. S., Muniz, Y. C. N., Simões, R. T., Carosella, E. D., Moreau, P., & Donadi, E. A. (2009) · Genes and Immunity · doi:10.1038/gene.2009.74 · Cited by 212 · see citing works

Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges

Noman, M. Z., Hasmim, M., Lequeux, A., Xiao, M., Duhem, C., Chouaı̈b, S., Berchem, G., & Janji, B. (2019) · Cells · doi:10.3390/cells8091083 · Cited by 215 · see citing works

The immunosuppressive molecule HLA-G and its clinical implications

González, Á., Rebmann, V., LeMaoult, J., Horn, P. A., Carosella, E. D., & Alegre, E. (2012) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.677947 · Cited by 197 · see citing works

Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy

Li, Y., Patel, S. P., Roszik, J., & Qin, Y. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01591 · Cited by 195 · see citing works

KIR2DL4 (CD158d): An activation receptor for HLA-G

Rajagopalan, S., & Long, E. O. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00258 · Cited by 202 · see citing works

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells

Chen, P., Yen, M., Liu, K., Sytwu, H., & Yen, B. L. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-49 · Cited by 180 · see citing works

The role of classical and non-classical HLA class I antigens in human tumors

Bukur, J., Jasinski‐Bergner, S., & Seliger, B. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.03.003 · Cited by 174 · see citing works

In silico analysis of microRNAS targeting the HLA-G 3′ untranslated region alleles and haplotypes

Castelli, E. C., Moreau, P., Chiromatzo, A. O. E., Mendes‐Junior, C. T., Veiga-Castelli, L. C., Yaghi, L., Giuliatti, S., Carosella, E. D., & Donadi, E. A. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.07.028 · Cited by 164 · see citing works

Unraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects

Fontaine, M. J., Shih, H., Schäfer, R., & Pittenger, M. F. (2016) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2015.11.004 · Cited by 162 · see citing works

A Comprehensive Study of Polymorphic Sites along the HLA-G Gene: Implication for Gene Regulation and Evolution

Castelli, E. C., Mendes‐Junior, C. T., Veiga-Castelli, L. C., Roger, M., Moreau, P., & Donadi, E. A. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr138 · Cited by 168 · see citing works

Role of non-classical MHC class I molecules in cancer immunosuppression

Kochan, G. T., Escors, D., Breckpot, K., & Guerrero‐Setas, D. (2013) · OncoImmunology · doi:10.4161/onci.26491 · Cited by 160 · see citing works

Transplantation of Human Amnion Epithelial Cells Reduces Hepatic Fibrosis in Immunocompetent CCl 4 -Treated Mice

Manuelpillai, U., Tchongue, J., Lourensz, D., Vaghjiani, V., Samuel, C. S., Liu, A., Williams, E. D., & Sievert, W. (2010) · Cell Transplantation · doi:10.3727/096368910x504496 · Cited by 152 · see citing works

Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17

Agaugué, S., Carosella, E. D., & Rouas‐Freiss, N. (2011) · Blood · doi:10.1182/blood-2010-07-294389 · Cited by 142 · see citing works

Tumor Microenvironment: A New Treatment Target for Cancer

Tsai, M., Chang, W., Huang, M., & Kuo, P. (2014) · ISRN Biochemistry · doi:10.1155/2014/351959 · Cited by 139 · see citing works

Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy

Lin, A., & Yan, W. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00083 · Cited by 137 · see citing works

Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

Amiot, L., Ferrone, S., Grosse‐Wilde, H., & Seliger, B. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0583-4 · Cited by 135 · see citing works

ILT2/HLA‐G interaction impairs NK‐cell functions through the inhibition of the late but not the early events of the NK‐cell activating synapse

Favier, B., LeMaoult, J., Lesport, E., & Carosella, E. D. (2009) · The FASEB Journal · doi:10.1096/fj.09-135194 · Cited by 131 · see citing works

Molecular Pathways: Human Leukocyte Antigen G (HLA-G)

Curigliano, G., Criscitiello, C., Gelao, L., & Goldhirsch, A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3697 · Cited by 127 · see citing works

Tolerance versus immune response — MicroRNAs as important elements in the regulation of the HLA-G gene expression

Veit, T. D., & Chies, J. A. B. (2008) · Transplant Immunology · doi:10.1016/j.trim.2008.11.001 · Cited by 124 · see citing works

HLA-G Molecules in Autoimmune Diseases and Infections

Rizzo, R., Bortolotti, D., Bolzani, S., & Fainardi, E. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00592 · Cited by 123 · see citing works

Mesenchymal stem cells and cardiac repair

Neßelmann, C., Ma, N., Bieback, K., Wagner, W., Ho, A. D., Konttinen, Y. T., Zhang, H., Hinescu, M. E., & Steinhoff, G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00457.x · Cited by 121 · see citing works

microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer

Goh, J. N., Loo, S. Y., Datta, A., Siveen, K. S., Yap, W. N., Cai, W., Shin, E. M., Wang, C., Kim, J. E., Chan, M., et al. (2015) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12176 · Cited by 118 · see citing works

The Dual Role of HLA-G in Cancer

Rouas‐Freiss, N., Moreau, P., LeMaoult, J., & Carosella, E. D. (2014) · Journal of Immunology Research · doi:10.1155/2014/359748 · Cited by 116 · see citing works

Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors

Avanzini, M. A., Bernardo, M. E., Cometa, A. M., Perotti, C. G., Zaffaroni, N., Novara, F., Visai, L., Moretta, A., Fante, C. D., Villa, R., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.006171 · Cited by 114 · see citing works

Melanoma cells become resistant to NK ‐cell‐mediated killing when exposed to NK ‐cell numbers compatible with NK ‐cell infiltration in the tumor

Balsamo, M., Vermi, W., Parodi, M., Pietra, G., Manzini, C., Queirolo, P., Lonardi, S., Augugliaro, R., Moretta, A., Facchetti, F., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142179 · Cited by 110 · see citing works

Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices

Marco, M. D., Schuster, H., Backert, L., Ghosh, M., Rammensee, H., & Stevanović, S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700938 · Cited by 102 · see citing works

HLA-G-mediated NK cell senescence promotes vascular remodeling: implications for reproduction

Rajagopalan, S. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.53 · Cited by 106 · see citing works

Non‐classical transcriptional regulation of HLA‐G: an update

Moreau, P., Flajollet, S., & Carosella, E. D. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00800.x · Cited by 106 · see citing works

CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis

Brown, R. D., Kabani, K., Favaloro, J., Yang, S., Ho, P. J., Gibson, J., Fromm, P. D., Suen, H., Woodland, N., Nassif, N. T., et al. (2012) · Blood · doi:10.1182/blood-2012-03-416792 · Cited by 105 · see citing works

The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells

Rizzo, R., Vercammen, M. J., de Velde, H. V., Horn, P. A., & Rebmann, V. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0578-1 · Cited by 104 · see citing works

Immunomodulatory Properties of HLA-G in Infectious Diseases

Amiot, L., Vu, N., & Samson, M. (2014) · Journal of Immunology Research · doi:10.1155/2014/298569 · Cited by 98 · see citing works

HLA-G–dependent suppressor cells: Diverse by nature, function, and significance

Carosella, E. D., HoWangYin, K.-Y., Favier, B., & LeMaoult, J. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.08.280 · Cited by 95 · see citing works

The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells

Carosella, E. D., Gregori, S., & LeMaoult, J. (2011) · Blood · doi:10.1182/blood-2011-07-370742 · Cited by 95 · see citing works

Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors

HoWangYin, K.-Y., Loustau, M., Wu, J., Alegre, E., Daouya, M., Caumartin, J., Sousa, S., Horuzsko, A., Carosella, E. D., & LeMaoult, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1069-3 · Cited by 91 · see citing works

Regulation of T‐cell immunity by leucocyte immunoglobulin‐like receptors: innate immune receptors for self on antigen‐presenting cells

Anderson, K. J., & Allen, R. L. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03097.x · Cited by 87 · see citing works

Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions

Avril, T., Saïkali, S., Vauléon, É., Jary, A., Hamlat, A., de Tayrac, M., Mosser, J., & Quillien, V. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.04.003 · Cited by 87 · see citing works

T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible

Huang, Y., Zozulya, A. L., Weidenfeller, C., Schwab, N., & Wiendl, H. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008649 · Cited by 83 · see citing works

The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients

König, L., Kasimir‐Bauer, S., Hoffmann, O., Bittner, A., Wagner, B., Manvailer, L. F. S., Schramm, S., Bánkfalvi, Á., Giebel, B., Kimmig, R., et al. (2016) · Human Immunology · doi:10.1016/j.humimm.2016.01.002 · Cited by 82 · see citing works

Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors

Jan, C., Huang, S., Canoll, P., Bruce, J. N., Lin, Y., Pan, C., Lu, H.-M., Chiu, S., & Cho, D. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003050 · Cited by 81 · see citing works

Human leukocyte antigen-G in the male reproductive system and in seminal plasma

Larsen, M. H., Bzorek, M., Pass, M. B., Larsen, L. G., Nielsen, M. W., Svendsen, S. G., Lindhard, A., & Hviid, T. V. F. (2011) · Molecular Human Reproduction · doi:10.1093/molehr/gar052 · Cited by 81 · see citing works

Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis

Amiot, L., Vu, N., Rauch, M., L’Helgoualc’h, A., Chalmel, F., Gascan, H., Turlin, B., Guyader, D., & Samson, M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.006 · Cited by 80 · see citing works

CD8+PD-1–ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G

Dumont, C., Jacquier, A., Verine, J., Noël, F., Goujon, A., Wu, C., Hung, T., Desgrandchamps, F., Culine, S., Carosella, E. D., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0764 · Cited by 78 · see citing works

microRNAs targeting the immunomodulatory HLA-G gene: A new survey searching for microRNAs with potential to regulate HLA-G

Porto, I. D. O. P., Mendes‐Junior, C. T., Felício, L. P., Georg, R. D. C., Moreau, P., Donadi, E. A., Chies, J. A. B., & Castelli, E. C. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.01.030 · Cited by 78 · see citing works

Emerging topics and new perspectives on HLA-G

Fainardi, E., Castellazzi, M., Stignani, M., Morandi, F., Sana, G., Gonzalez, R., Pistoia, V., Baricordi, O. R., Sokal, E. M., & Peña, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0584-3 · Cited by 76 · see citing works

Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G

Fernando, M. M. A., Freudenberg, J., Lee, A., Morris, D. L., Boteva, L., Rhodes, B., González‐Escribano, M. F., López‐Nevot, M. Á., Navarra, S., Gregersen, P. K., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200808 · Cited by 75 · see citing works

New insights into HLA ‐G mediated tolerance

Amodio, G., de Albuquerque, R. S., & Gregori, S. (2014) · Tissue Antigens · doi:10.1111/tan.12427 · Cited by 73 · see citing works

Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis

Andersson, E. K., Poschke, I. C., Villabona, L. E. E., Carlson, J. W., Lundqvist, A., Kiessling, R. W., Seliger, B., & Masucci, G. V. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1052213 · Cited by 72 · see citing works

Immunohistochemical Study of HLA-G Expression in Lung Transplant Recipients

Brugière, O., Thabut, G., Pretolani, M., Krawice-Radanne, I., Dill, C., Herbreteau, A., Poras, I., Moreau, P., Colombat, M., Danel, C. J., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02650.x · Cited by 72 · see citing works

HLA-G Expression in Human Embryonic Stem Cells and Preimplantation Embryos

Verloes, A., de Velde, H. V., LeMaoult, J., Mateizel, I., Cauffman, G., Horn, P. A., Carosella, E. D., Devroey, P., Waele, M. D., Rebmann, V., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001081 · Cited by 71 · see citing works

Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2

Yaghi, L., Poras, I., Simões, R. T., Donadi, E. A., Tost, J., Daunay, A., de Almeida, B. S., Carosella, E. D., & Moreau, P. (2016) · Oncotarget · doi:10.18632/oncotarget.11628 · Cited by 71 · see citing works

Role of HLA-G as a Predictive Marker of Low Risk of Chronic Rejection in Lung Transplant Recipients: A Clinical Prospective Study

Brugière, O., Thabut, G., Krawice-Radanne, I., Rizzo, R., Dauriat, G., Danel, C. J., Suberbielle, C., Mal, H., Stern, M., Schilte, C., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12977 · Cited by 70 · see citing works

HLA‐G: Function, polymorphisms and pathology

Arnaiz‐Villena, A., Juárez, I., Suárez‐Trujillo, F., López‐Nares, A., Vaquero‐Yuste, C., Palacio-Grüber, J., & Martín‐Villa, J. M. (2020) · International Journal of Immunogenetics · doi:10.1111/iji.12513 · Cited by 69 · see citing works

Specific central nervous system recruitment of HLA‐G+ regulatory T cells in multiple sclerosis

Huang, Y., Zozulya, A. L., Weidenfeller, C., Metz, I., Buck, D., Toyka, K. V., Brück, W., & Wiendl, H. (2009) · Annals of Neurology · doi:10.1002/ana.21705 · Cited by 69 · see citing works

Prognostic relevance of soluble human leukocyte antigen–G and total human leukocyte antigen class I molecules in lung cancer patients

Schütt, P., Schütt, B., Switala, M., Bauer, S., Stamatis, G., Opalka, B., Eberhardt, W., Schüler, M., Horn, P. A., & Rebmann, V. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.02.015 · Cited by 69 · see citing works

The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology

Rebmann, V., König, L., Nardi, F. D. S., Wagner, B., Manvailer, L. F. S., & Horn, P. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00173 · Cited by 69 · see citing works

Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells

Pezzolo, A., Parodi, F., Marimpietri, D., Raffaghello, L., Cocco, C., Pistorio, A., Mosconi, M., Gambini, C., Cilli, M., Deaglio, S., et al. (2011) · Cell Research · doi:10.1038/cr.2011.38 · Cited by 68 · see citing works

Pervasive haplotypic variation in the spliceo-transcriptome of the human major histocompatibility complexPreprint

Vandiedonck, C., Taylor, M. S., Lockstone, H. E., Plant, K., Taylor, J. M., Durrant, C., Broxholme, J., Fairfax, B. P., & Knight, J. C. (2011) · Genome Research · doi:10.1101/gr.116681.110 · Cited by 69 · see citing works

The tolerogenic molecule HLA-G

Carosella, E. D. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.02.011 · Cited by 67 · see citing works

RREB-1 Is a Transcriptional Repressor of HLA-G

Flajollet, S., Poras, I., Carosella, E. D., & Moreau, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902053 · Cited by 67 · see citing works

Inhibition of human Vγ9Vδ2 T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer

Lesport, E., Baudhuin, J., Sousa, S., LeMaoult, J., Zamborlini, A., Rouas‐Freiss, N., Carosella, E. D., & Favier, B. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0632-7 · Cited by 64 · see citing works

Clinical relevance and functional implications for human leucocyte antigen‐g expression in non‐small‐cell lung cancer

Lin, A., Zhu, C., Chen, H. ‐., Chen, B. ‐., Zhang, X., Zhang, J. ‐., Wang, Q., Zhou, W., Hu, W., Yang, H., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00858.x · Cited by 65 · see citing works

The role of HLA-G in immunity and hematopoiesis

Carosella, E. D., Gregori, S., Rouas‐Freiss, N., LeMaoult, J., Menier, C., & Favier, B. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0579-0 · Cited by 65 · see citing works

Comparison of Mesenchymal Stem Cells Isolated From Pulp and Periodontal Ligament

Hakki, S. S., Kayış, S. A., Hakki, E. E., Bozkurt, Ş. B., Duruksu, G., HALBUTOĞULLARI, Z. S., Turaç, G., & Karaöz, E. (2014) · Journal of Periodontology · doi:10.1902/jop.2014.140257 · Cited by 64 · see citing works

Generation of hypoimmunogenic human pluripotent stem cells via expression of membrane-bound and secreted β2m-HLA-G fusion proteins

Shi, L., Li, W., Liu, Y., Chen, Z., Hui, Y., Hao, P., Xu, X., Zhang, S., Feng, H., Zhang, B., et al. (2020) · Stem Cells · doi:10.1002/stem.3269 · Cited by 63 · see citing works

Hair Follicle Mesenchyme-Associated PD-L1 Regulates T-Cell Activation Induced Apoptosis: A Potential Mechanism of Immune Privilege

Wang, X., Marr, A. K., Breitkopf, T., Leung, G., Hao, J., Wang, E., Kwong, N., Akhoundsadegh, N., Chen, L., Mui, A., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.368 · Cited by 62 · see citing works

Endosomal Signaling and a Novel Pathway Defined by the Natural Killer Receptor KIR2DL4 (CD158d)

Rajagopalan, S. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01112.x · Cited by 63 · see citing works

Hypoxic Modulation of HLA-G Expression through the Metabolic Sensor HIF-1 in Human Cancer Cells

Garziera, M., Scarabel, L., & Toffoli, G. (2017) · Journal of Immunology Research · doi:10.1155/2017/4587520 · Cited by 59 · see citing works

HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus

Simões, R. T., Gonçalves, M. A. G., Castelli, E. C., Mendes‐Junior, C. T., Bettini, J. S. R., Discorde, M. L., Duarte, G. G., Quintana, S. M., Simões, A. L., Moreau, P., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.67 · Cited by 59 · see citing works

What the HLA-I!—Classical and Non-classical HLA Class I and Their Potential Roles in Type 1 Diabetes

Wyatt, R. C., Lanzoni, G., Russell, M. A., Gerling, I., & Richardson, S. J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1245-z · Cited by 59 · see citing works

Concise review: Combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy

Naji, A., Rouas‐Freiss, N., Dürrbach, A., Carosella, E. D., Sensebé, L., & Deschaseaux, F. (2013) · Stem Cells · doi:10.1002/stem.1494 · Cited by 58 · see citing works

Altered HLA Class I and HLA-G Expression Is Associated with IL-10 Expression in Patients with Cervical Cancer

Rodrı́guez, J. A., Galeano, L., Palacios, D. M., Gómez, C., Serrano, M. L., Bravo, M. M., & Cómbita, A. L. (2011) · Pathobiology · doi:10.1159/000334089 · Cited by 58 · see citing works

Neutrophil Gelatinase-Associated Lipocalin Increases HLA-G+/FoxP3+ T-Regulatory Cell Population in an In Vitro Model of PBMC

Manna, G. L., Ghinatti, G., Tazzari, P. L., Alviano, F., Ricci, F., Capelli, I., Cuna, V., Todeschini, P., Brunocilla, E., Pagliaro, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089497 · Cited by 55 · see citing works

Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations

Yücesoy, B., Talzhanov, Y. A., Johnson, V. J., Wilson, N. W., Biagini, R. E., Wang, W., Frye, B. L., Weissman, D. N., Germolec, D. R., Luster, M. I., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.09.026 · Cited by 57 · see citing works

Efficient Derivation and Concise Gene Expression Profiling of Human Embryonic Stem Cell-Derived Mesenchymal Progenitors (EMPs)

Yen, M., Hou, C., Peng, K., Tseng, P., Jiang, S. S., Shun, C., Chen, Y., & Kuo, M. (2011) · Cell Transplantation · doi:10.3727/096368910x564067 · Cited by 56 · see citing works

HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas

Rutten, M. J., Dijk, F., Savci-Heijink, C. D., Buist, M. R., Kenter, G. G., van de Vijver, M. J., & Jordanova, E. S. (2014) · Journal of Immunology Research · doi:10.1155/2014/274584 · Cited by 55 · see citing works

Soluble HLA-G Inhibits Myeloid Dendritic Cell Function in HIV-1 Infection by Interacting with Leukocyte Immunoglobulin-Like Receptor B2

Huang, J., Burke, P. S., Yang, Y., Seiss, K., Beamon, J., Cung, T. D. H., Tóth, I., Pereyra, F., Lichterfeld, M. D., & Yu, X. G. (2010) · Journal of Virology · doi:10.1128/jvi.01292-10 · Cited by 55 · see citing works

Liver HLA-G expression is associated with multiple clinical and histopathological forms of chronic hepatitis B virus infection

Souto, F. J. D., Crispim, J. C. O., Ferreira, S. D. C., da Silva, A. S. M., Bassi, C. L., Soares, C. P., Zucoloto, S., Rouas‐Freiss, N., Moreau, P., Martinelli, A. L. C., et al. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01286.x · Cited by 54 · see citing works

First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G

Anna, F., Bôle‐Richard, E., LeMaoult, J., Escande, M. C., Lecomte, M., Certoux, J.-M., Souque, P., Garnache‐Ottou, F., Adotévi, O., Langlade‐Demoyen, P., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001998 · Cited by 56 · see citing works

Expression of the nonclassical HLA-G and HLA-E molecules in laryngeal lesions as biomarkers of tumor invasiveness.

Silva, T. G., Crispim, J. C. O., Miranda, F. A., Hassumi, M. K., de Mello, J. M. Y., Simões, R. T., Souto, F. J. D., Soares, E. G., Donadi, E. A., & Soares, C. P. (2011) · PubMed · doi:10.14670/hh-26.1487 · Cited by 53 · see citing works

The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune Cells

Liu, L., Wang, L., Zhao, L., He, C., & Wang, G. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.597468 · Cited by 53 · see citing works

Expansion of CD 4+ HLA ‐G+ T Cell in Human Pregnancy is Impaired in Pre‐eclampsia

Hsu, P. S., Santner‐Nanan, B., Joung, S. J. S., Peek, M. J., & Nanan, R. K. H. (2014) · American Journal of Reproductive Immunology · doi:10.1111/aji.12195 · Cited by 52 · see citing works

Surface Expression of HLA-G is Involved in Mediating Immunomodulatory Effects of Placenta-Derived Multipotent Cells (PDMCs) towards Natural Killer Lymphocytes

Liu, K.-J., Wang, C.-J., Chang, C.-J., Hu, H.-I., Hsu, P., Wu, Y.-C., Bai, C., Sytwu, H., & Yen, B. L. (2011) · Cell Transplantation · doi:10.3727/096368911x580590 · Cited by 52 · see citing works

Association between HLA-G 3'UTR 14-bp ins/del polymorphism and susceptibility to breast cancer

Eskandari‐Nasab, E., Hashemi, M. M., Hasani, S., Omrani, M., Taheri, M., & Mashhadi, M. A. (2013) · Cancer Biomarkers · doi:10.3233/cbm-130364 · Cited by 51 · see citing works

Trogocytosis-mediated immune evasion in the tumor microenvironment

Kim, J., Park, S. Y., Kim, J., Kim, Y. W., Yoon, H. M., Rayhan, B. R., Jeong, J., Bothwell, A. L. M., & Shin, J. H. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01364-2 · Cited by 50 · see citing works

HLA-G polymorphisms and soluble HLA-G protein levels in women with recurrent pregnancy loss from Basrah province in Iraq

Jassem, R. M., Shani, W. S., Loisel, D. A., Sharief, M., Billstrand, C., & Ober, C. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.05.009 · Cited by 50 · see citing works

HLA-G5 Induces IL-4 Secretion Critical for Successful Pregnancy through Differential Expression of ILT2 Receptor on Decidual CD4+ T Cells and Macrophages

Lombardelli, L., Aguerre‐Girr, M., Logiodice, F., Kullolli, O., Casart, Y. C., Polgár, B., Berrebi, A., Romagnani, S., Maggi, E., Bouteiller, P. P. L., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300567 · Cited by 47 · see citing works

The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy

Mejía-Guarnizo, L. V., Monroy-Camacho, P. S., Turizo-Smith, A. D., & Rodríguez-García, J. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1298571 · Cited by 48 · see citing works

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights

on behalf of the Solid Tumor Working Party of European Blood and Marrow Transplantation Society (EBMT), Ravelli, A., Reuben, J. M., Lanza, F., Anfossi, S., Cappelletti, M. R., Zanotti, L., Gobbi, A., Senti, C., Brambilla, P., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3944-7 · Cited by 47 · see citing works

Characterization of HLA‐G expression in renal cell carcinoma

Li, B., Lin, A., Zhang, X. ‐., Zhang, X., Zhang, J. ‐., Wang, Q., Zhou, W., Chen, H. ‐., Wang, T., & Yan, W. (2009) · Tissue Antigens · doi:10.1111/j.1399-0039.2009.01302.x · Cited by 47 · see citing works

Human leucocyte antigen-G polymorphisms are associated with cervical squamous cell carcinoma risk in Taiwanese women

Yang, Y., Chang, T., Chen, T.-C., Lin, W., Chang, S.-C., & Lee, Y. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.10.018 · Cited by 45 · see citing works

HLA-G expression in gastric carcinoma: clinicopathological correlations and prognostic impact

Murdaca, G., Calamaro, P., Lantieri, F., Pigozzi, S., Mastracci, L., Grillo, F., Magnani, O., Ceppa, P., Puppo, F., & Fiocca, R. (2018) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-018-2379-0 · Cited by 43 · see citing works

Human Leukocyte Antigen G Expression in Breast Cancer: Role in Immunosuppression

Elliott, R. L., Jiang, X. P., Phillips, J. T., Barnett, B. G., & Head, J. F. (2011) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2010.0924 · Cited by 42 · see citing works

Synthetic HLA‐G proteins for therapeutic use in transplantation

LeMaoult, J., Daouya, M., Wu, J., Loustau, M., Horuzsko, A., & Carosella, E. D. (2013) · The FASEB Journal · doi:10.1096/fj.13-228247 · Cited by 42 · see citing works

Review in translational hematology Beyond the increasing complexity of the immunomodulatory HLA-G molecule

Carosella, E. D., Favier, B., Rouas‐Freiss, N., & LeMaoult, J. (2016)

Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases

Morandi, F., Rizzo, R., Fainardi, E., Rouas‐Freiss, N., & Pistoia, V. (2016) · Journal of Immunology Research · doi:10.1155/2016/4326495 · Cited by 126 · see citing works

Harnessing the immunomodulatory properties of HLA-G for advanced immunotherapies

Beli, X., Savvopoulos, N., Kefala, D., Lysandrou, M., Liga, M., & Spyridonidis, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1716778 · Cited by 9 · see citing works

Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditions

Bortolotti, D. (2014) · World Journal of Methodology · doi:10.5662/wjm.v4.i1.11 · Cited by 18 · see citing works

HLA-G

Carosella, E. D., Rouas‐Freiss, N., Roux, D. T., Moreau, P., & LeMaoult, J. (2015) · Advances in immunology · doi:10.1016/bs.ai.2015.04.001 · Cited by 395 · see citing works